AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers products for use in the areas of allergy, gastrointestinal, cold and flu, digestive health, eye care, first aid, nail care, pain management, skin care, vitamins, and supplements, as well as other products. The company has collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
Metrics to compare | AFP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAFPPeersSector | |
---|---|---|---|---|
P/E Ratio | 23.7x | −0.1x | −0.4x | |
PEG Ratio | −0.91 | 0.00 | 0.00 | |
Price/Book | 2.9x | 0.7x | 2.6x | |
Price / LTM Sales | 1.4x | 1.1x | 2.9x | |
Upside (Analyst Target) | - | 258.1% | 53.5% | |
Fair Value Upside | Unlock | 10.0% | 9.5% | Unlock |